Antigen specific multi epitope vaccines

Details for Australian Patent Application No. 2007298494 (hide)

Owner Vaxil Biotherapeutics Ltd.

Inventors Carmon, Lior

Agent Shelston IP

Pub. Number AU-A-2007298494

PCT Pub. Number WO2008/035350

Priority 60/846,087 21.09.06 US

Filing date 23 September 2007

Wipo publication date 27 March 2008

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

21 May 2009 PCT application entered the National Phase

  PCT publication WO2008/035350 Priority application(s): WO2008/035350

28 May 2009 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Vaxil Biotherapeutics Ltd., Application No. 2007298494, under INID (71), add the co-applicant Lior Carmon

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007298506-RNA interference mediated inhibition of Aurorakinase B and its combinations as anticancer therapy

2007298490-Improved device and method for smart card assisted digital content purchase and storage